Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Type 2 Diabetic Medicine: An Overview of Current Therapies and Future Directions
*Corresponding Author:Received Date: Nov 01, 2024 / Published Date: Nov 30, 2024
Copyright: © 0 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Type 2 diabetes mellitus (T2DM) is a prevalent chronic metabolic disorder characterized by insulin resistance and progressive β-cell dysfunction. With its increasing incidence globally, effective management strategies are essential to mitigate complications such as cardiovascular disease and neuropathy. This article provides an overview of current pharmacological therapies for T2DM, including metformin, sulfonylureas, thiazolidinediones, DPP-4 inhibitors, GLP-1 receptor agonists, and SGLT2 inhibitors, highlighting their mechanisms of action, benefits, and potential side effects. Additionally, it discusses the importance of personalized medicine, the role of combination therapies, and emerging treatments that target novel pathways. The integration of digital health technologies is also explored as a means to enhance patient engagement and management outcomes. Overall, a comprehensive, multifaceted approach is vital for optimizing T2DM management in the face of a growing global epidemic.
